1,446
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Knowledge of and support for cancer patient pathways among general practitioners and other physicians – a study from Sweden

, &
Pages 17-22 | Received 09 Jan 2020, Accepted 10 Dec 2020, Published online: 08 Feb 2021

References

  • Vedsted P, Olesen F. Early diagnosis of cancer-the role of general practice. Scand J Prim Health Care. 2009;27(4):193–194.
  • Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
  • Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
  • Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009;101 (Suppl 2):S125–S129.
  • Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-a national Danish project. Health Policy. 2012;105(1):65–70.
  • Malterud K, Reventlow S, Guassora AD. Diagnostic knowing in general practice: interpretative action and reflexivity. Scand J Prim Health Care. 2019;37(4):393–401.
  • Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(S1):S92–S107.
  • Di Girolamo C, Walters S, Gildea C, et al. Can we assess cancer waiting time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013. PLoS One. 2018;13(8):e0201288.
  • Jensen H, Torring ML, Vedsted P. Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care. BMC Cancer. 2017;17(1):627.
  • Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS patients: cancer. Br J Cancer. 2005;92(11):1959–1970.
  • Wilkens J, Thulesius H, Schmidt I, et al. The 2015 National Cancer Program in Sweden: Introducing standardized care pathways in a decentralized system. Health Policy. 2016;120(12):1378–1382.
  • Scheel BI, Holtedahl K. Symptoms, signs, and tests: the general practitioner's comprehensive approach towards a cancer diagnosis. Scand J Prim Health Care. 2015;33(3):170–177.
  • Ewing M, Naredi P, Nemes S, et al. Increased consultation frequency in primary care, a risk marker for cancer: a case-control study. Scand J Prim Health Care. 2016;34(2):205–212.
  • Solvang M, Elnegaard S, Jarbol DE. Urological symptoms among 23,240 men in the general danish population - concerns about symptoms, their persistence and influence on primary care contacts. Scand J Prim Health Care. 2018;36(3):227–236.
  • Usher-Smith JA, Sharp SJ, Griffin SJ. The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ. 2016;353:i3139.
  • Ingebrigtsen SG, Scheel BI, Hart B, et al. Frequency of 'warning signs of cancer' in Norwegian general practice, with prospective recording of subsequent cancer. Fam Pract. 2013;30(2):153–160.
  • Opdal PO, Meland E, Hjorleifsson S. Dilemmas of medical overuse in general practice - a focus group study. Scand J Prim Health Care. 2019;37(1):135–140.
  • Smeds M, Poksinska BB. The effects of cancer care pathways on waiting times. IJQSS. 2019;11(2):204–216.
  • Delilovic S, Hasson H, Ahstrom M, et al. Implementing standardized cancer patient pathways (CPPs) - a qualitative study exploring the perspectives of health care professionals. BMC Health Serv Res. 2019;19(1):577.
  • Nielsen N, Vedsted P, Jensen H. Risk of cancer and repeated urgent referral after negative investigation for cancer. Fam Pract. 2018;35(5):582–588.